PortfoliosLab logoPortfoliosLab logo
TMO vs. ITOCY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TMO vs. ITOCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Thermo Fisher Scientific Inc. (TMO) and Itochu Corp ADR (ITOCY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMO achieves a -18.87% return, which is significantly lower than ITOCY's -8.19% return. Over the past 10 years, TMO has underperformed ITOCY with an annualized return of 12.28%, while ITOCY has yielded a comparatively higher 18.48% annualized return.


TMO

1D
-0.67%
1M
1.00%
YTD
-18.87%
6M
-17.21%
1Y
17.28%
3Y*
-2.93%
5Y*
1.21%
10Y*
12.28%

ITOCY

1D
1.57%
1M
-9.65%
YTD
-8.19%
6M
-3.02%
1Y
10.95%
3Y*
15.64%
5Y*
14.03%
10Y*
18.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMO vs. ITOCY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TMO
Thermo Fisher Scientific Inc.
-18.87%11.78%-1.72%-3.36%-17.29%43.54%43.72%45.55%18.21%35.03%
ITOCY
Itochu Corp ADR
-8.19%30.16%22.57%30.30%1.54%6.60%24.95%38.77%-5.54%46.71%

Correlation

The correlation between TMO and ITOCY is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jan 30, 2006

0.24

Fundamentals

Market Cap

TMO:

$175.17B

ITOCY:

$81.15B

EPS

TMO:

$18.22

ITOCY:

$86.32

PE Ratio

TMO:

25.78

ITOCY:

0.13

PS Ratio

TMO:

3.91

ITOCY:

0.01

PB Ratio

TMO:

3.37

ITOCY:

0.01

Total Revenue (TTM)

TMO:

$45.20B

ITOCY:

$15.03T

Gross Profit (TTM)

TMO:

$17.81B

ITOCY:

$2.51T

EBITDA (TTM)

TMO:

$11.16B

ITOCY:

$1.26T

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMO vs. ITOCY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMO
TMO Risk / Return Rank: 5757
Overall Rank
TMO Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
TMO Sortino Ratio Rank: 5757
Sortino Ratio Rank
TMO Omega Ratio Rank: 5454
Omega Ratio Rank
TMO Calmar Ratio Rank: 5555
Calmar Ratio Rank
TMO Martin Ratio Rank: 5555
Martin Ratio Rank

ITOCY
ITOCY Risk / Return Rank: 5353
Overall Rank
ITOCY Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
ITOCY Sortino Ratio Rank: 5050
Sortino Ratio Rank
ITOCY Omega Ratio Rank: 4848
Omega Ratio Rank
ITOCY Calmar Ratio Rank: 5454
Calmar Ratio Rank
ITOCY Martin Ratio Rank: 5757
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMO vs. ITOCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and Itochu Corp ADR (ITOCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TMOITOCYDifference
Sharpe ratioReturn per unit of total volatility

+0.15

Sortino ratioReturn per unit of downside risk

+0.27

Omega ratioGain probability vs. loss probability

1.13

1.09

+0.03

Calmar ratioReturn relative to maximum drawdown

0.55

0.50

+0.05

Martin ratioReturn relative to average drawdown

1.23

1.37

-0.14

TMO vs. ITOCY - Sharpe Ratio Comparison

The current TMO Sharpe Ratio is 0.56, which is higher than the ITOCY Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of TMO and ITOCY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TMOITOCYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.56

0.41

+0.15

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

0.54

-0.49

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.47

0.77

-0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

0.40

0.39

+0.01

Drawdowns

TMO vs. ITOCY - Drawdown Comparison

The maximum TMO drawdown since its inception was -71.16%, roughly equal to the maximum ITOCY drawdown of -69.11%. Use the drawdown chart below to compare losses from any high point for TMO and ITOCY.


Loading charts...

Drawdown Indicators


TMOITOCYDifference

Max Drawdown

Largest peak-to-trough decline

-71.16%

-69.11%

-2.05%

Max Drawdown (1Y)

Largest decline over 1 year

-31.38%

-22.03%

-9.35%

Max Drawdown (3Y)

Largest decline over 3 years

-37.28%

-26.47%

-10.81%

Max Drawdown (5Y)

Largest decline over 5 years

-40.95%

-30.18%

-10.77%

Max Drawdown (10Y)

Largest decline over 10 years

-40.95%

-30.18%

-10.77%

Current Drawdown

Current decline from peak

-28.76%

-20.80%

-7.96%

Average Drawdown

Average peak-to-trough decline

-18.02%

-14.27%

-3.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.09%

8.03%

+6.06%

Volatility

TMO vs. ITOCY - Volatility Comparison

Thermo Fisher Scientific Inc. (TMO) has a higher volatility of 9.96% compared to Itochu Corp ADR (ITOCY) at 6.96%. This indicates that TMO's price experiences larger fluctuations and is considered to be riskier than ITOCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TMOITOCYDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.96%

6.96%

+3.00%

Volatility (6M)

Calculated over the trailing 6-month period

21.57%

21.14%

+0.43%

Volatility (1Y)

Calculated over the trailing 1-year period

31.02%

26.91%

+4.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.13%

26.23%

+0.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.33%

23.99%

+2.34%

Dividends

TMO vs. ITOCY - Dividend Comparison

TMO's dividend yield for the trailing twelve months is around 0.37%, while ITOCY has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ITOCY
Itochu Corp ADR
0.00%1.07%1.35%0.00%0.00%0.00%0.00%1.85%3.93%2.83%3.68%3.30%
TMO
Thermo Fisher Scientific Inc.
0.37%0.30%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%

Financials

TMO vs. ITOCY - Financials Comparison

This section allows you to compare key financial metrics between Thermo Fisher Scientific Inc. and Itochu Corp ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00T2.00T3.00T4.00T20222023202420252026
11.01B
3.91T
(TMO) Total Revenue
(ITOCY) Total Revenue
Values in USD except per share items

TMO vs. ITOCY - Profitability Comparison

The chart below illustrates the profitability comparison between Thermo Fisher Scientific Inc. and Itochu Corp ADR over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%20222023202420252026
40.7%
17.1%
Portfolio components
TMO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported a gross profit of 4.48B and revenue of 11.01B. Therefore, the gross margin over that period was 40.7%.

ITOCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Itochu Corp ADR reported a gross profit of 666.75B and revenue of 3.91T. Therefore, the gross margin over that period was 17.1%.

TMO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported an operating income of 1.86B and revenue of 11.01B, resulting in an operating margin of 16.9%.

ITOCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Itochu Corp ADR reported an operating income of 178.67B and revenue of 3.91T, resulting in an operating margin of 4.6%.

TMO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported a net income of 1.65B and revenue of 11.01B, resulting in a net margin of 15.0%.

ITOCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Itochu Corp ADR reported a net income of 198.57B and revenue of 3.91T, resulting in a net margin of 5.1%.


Frequently Asked Questions


TMO and ITOCY have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TMO has higher volatility (9.96%) compared to ITOCY (6.96%). In terms of maximum drawdown, TMO dropped -71.16% vs ITOCY's -69.11%.

TMO currently has the higher Sharpe Ratio (0.56 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TMO and ITOCY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer